Literature DB >> 2198435

Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.

S M Haffner1, M P Stern, J Dunn, M Mobley, J Blackwell, R N Bergman.   

Abstract

The contributions of diminished insulin sensitivity and decreased insulin response to the development of non-insulin-dependent diabetes mellitus (NIDDM) remain controversial. Nondiabetics in high-risk populations for NIDDM, including Pima Indians and Mexican Americans, are characterized by obesity and hyperinsulinemia relative to nondiabetics in the lower-risk white population. However, it is not clear to what extent diminished insulin sensitivity in the high-risk groups reflects obesity per se or is an inherent characteristic of these groups. Insulin sensitivity and secretion were determined in 10 nonobese, normoglycemic Mexican Americans (mean body mass index [BMI], 23.8 kg/m2) and 11 normoglycemic non-Hispanic whites (mean BMI, 22.5 kg/m2) using the intravenous glucose tolerance test (IVGTT) and the minimal model approach of Bergman et al. Age, BMI, sum of skinfolds, and the ratio of waist-to-hip circumference (WHR) were similar in both ethnic groups. Mexican Americans had decreased insulin sensitivity compared with non-Hispanic whites (4.06 +/- 0.72 in Mexican Americans v 7.56 +/- 1.13 in non-Hispanic whites, P = .017). The areas under the C-peptide and insulin curves were significantly greater in Mexican Americans than in non-Hispanic whites (P less than .01), suggesting greater insulin secretion in the former. This study provides evidence for diminished insulin sensitivity and increased insulin response in young, nonobese, normoglycemic Mexican Americans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198435     DOI: 10.1016/0026-0495(90)90130-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Fructose-containing sugars and cardiovascular disease.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

3.  Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.

Authors:  G Nijpels; C Popp-Snijders; P J Kostense; L M Bouter; R J Heine
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 4.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 5.  Sleep health in U.S. Hispanic population.

Authors:  Jose S Loredo; Xavier Soler; Wayne Bardwell; Sonia Ancoli-Israel; Joel E Dimsdale; Lawrence A Palinkas
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

Review 6.  Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations.

Authors:  Arlan L Rosenbloom
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.

Authors:  Hassan R Mohamed; Mohamed Yaqoot Abdel-Azziz; Kkaled Refaat Zalata; Ahmed M M Abdel-Razik
Journal:  Int J Health Sci (Qassim)       Date:  2009-07

8.  Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study.

Authors:  Jøran Hjelmesæth; Jo Røislien; Njord Nordstrand; Dag Hofsø; Helle Hager; Anders Hartmann
Journal:  BMC Endocr Disord       Date:  2010-04-18       Impact factor: 2.763

9.  A sesquiterpene quinone, dysidine, from the sponge Dysidea villosa, activates the insulin pathway through inhibition of PTPases.

Authors:  Yu Zhang; Yan Li; Yue-wei Guo; Hua-liang Jiang; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

10.  Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents.

Authors:  Claudia M Toledo-Corral; Tanya L Alderete; Joyce Richey; Paola Sequeira; Michael I Goran; Marc J Weigensberg
Journal:  Acta Diabetol       Date:  2014-08-11       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.